fromwww.scientificamerican.com
4 months agoFrom Tragedy to EurekaThe Long Road to RSV Drugs
When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn't the only threat facing her son. Born a micro preemie at under 26 weeks, little Alistair was also at very high risk for severe disease from other germs, including respiratory syncytial virus (RSV). Ehrlich says she was terrified because it was a guaranteed hospital stay for him, and after he had already spent his first 134 days of life in a neonatal intensive care unit (ICU), I didn't want that for him anymore.